Biotech

All Articles

FDA anxious Iterum's urinary system disease medicine might result in antimicrobial resistance

.5 months after signing off on Utility Therapeutics' Pivya as the initial new procedure for simple u...

Eli Lilly leaps deeper right into AI with $409M Hereditary Leap deal

.Eli Lilly has actually vaulted in to an AI-enabled medicine invention offer, partnering along with ...

After FDA denial and also unemployments, Lykos CEO is actually leaving

.Lykos chief executive officer and also creator Amy Emerson is actually walking out, along with main...

Novartis kindles brand-new phase of Voyager deal with $15M capsid offer

.Novartis is opening a brand-new outpost in its own cooperation along with Voyager Rehabs, spending ...

Lilly articles more favorable information on its once a week blood insulin possibility

.On the heels of an FDA denial for its own main competing Novo Nordisk, Eli Lilly is actually making...

IN 8bio stops period 2 trial, lays off fifty percent of workforce

.Only a couple of months after dosing the very first client in a period 2 trial for freshly detected...

Lilly, Haya ink $1B biobuck excessive weight treaty to search dark genome

.Eli Lilly's search for excessive weight targets has led it to the darker genome. The Big Pharma has...

ArsenalBio raises $325M, pivots away from past lead property

.Toolbox Biosciences is proceeding up. The cell treatment firm has actually added on $325 million in...

Lilly- backed weight management biotech data IPO

.After raising $170 thousand back in February, metabolic disease-focused BioAge Labs has submitted t...

Aelis' marijuana usage drug flunks phase 2b, steering Indivior to rethink $100M option

.Aelis Farma's chances of safeguarding a simple, beneficial decision on a $100 million choice repaym...